Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says ⊕
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Eli Lilly opposes the White House's push to codify "most favored nation" drug pricing into law, CEO Dave Ricks said in an interview with CNBC.